Publication date: Oct 07, 2019
People with relapsing-remitting multiple sclerosis (RRMS) who don’t use disease-modifying therapies (DMTs) are more likely to have been misdiagnosed previously, and to have poorer relationships with their healthcare providers, the results of a new survey suggest. -People with relapsing forms of MS who don’t use DMTs represent a small portion of the community, but it is so important to understand the unmet needs and nuances of their patient journeys,” Tim Armand, co-founder and president of Health Union, said in a news release. Relationships with healthcare providers also seem to play a significant role in these decisions, as respondents who use DMTs were more likely to see a neurologist who specializes in treating MS, whereas those who don’t use DMTs were more likely to report not seeing a healthcare provider for MS at all. They were more likely to report actively seeking out information about new MS treatments, whereas respondents who have never used DMTs were more likely to say they’d prefer changing their lifestyle or diet, rather than taking medications.
|Multiple Sclerosis||Healthcare providers|
|disease||MESH||relapsing-remitting multiple sclerosis|
- #ECTRIMS2019 – MS Patients Should Be Informed about Pregnancy Risks and Family Planning, Experts Say
- #ECTRIMS2019 – Longer DMT Use and Female Sex Seen to Protect Against SPMS Conversion